A.G. Barr Reports Strong FY25/26 Performance with Double-Digit Profit Growth and Acquisitions of Fentimans and Frobishers

• IRN-BRU – modest growth in the second half after a flat first half, helped by marketing and distribution initiatives.
• Rubicon and Boost – described as delivering good performances.
• FUNKIN – declined over the year.
• Innovation – significantly expanded, with multiple new launches starting from January 2026.

That blend suggests the core portfolio is resilient, innovation is ramping up, and there is work to do in the cocktail mixer segment, where FUNKIN dipped. The upcoming redesigns of IRN-BRU and Rubicon in FY26/27 should keep the brands front-of-shelf.

Strategic moves – acquiring Fentimans and Frobishers

Barr is leaning into the Adult Soft Drinks category, which benefits from the ongoing trend of reduced alcohol consumption. The company has acquired two premium names:

• Frobishers Juices Ltd – acquired towards the end of the period for £13 million, funded from the company’s net cash position.
• Fentimans Ltd – completed after the year-end on 2 February 2026 for around £38 million, funded through a mix of cash and debt.

Both brands broaden Barr’s reach in premium adult occasions – Fentimans with its well-known “Botanical Brewing” soft drinks and mixers, Frobishers with premium natural fruit juices and soft drinks. Management expects cost synergies and notes integration will take place during FY26/27, with efficiencies beginning to come through from the second half.

Why these deals are interesting

• Category tailwind – Adult soft drinks are growing as consumers cut back on alcohol. These brands plug into that behaviour at premium price points.
• Portfolio fit – They complement IRN-BRU, Rubicon and Boost by adding more adult, mixer, and premium juice options.
• Synergies and accretion – Barr sees meaningful medium-term accretion from synergies. In plain English, they expect the deals to add to earnings over time as overlapping costs are taken out and scale benefits kick in.

Risks to watch: integration always demands focus, and the Fentimans deal introduces some debt (amount not disclosed). There is also execution risk in repositioning and scaling premium brands without diluting their distinctiveness. That said, Barr’s margin discipline and c.20% adjusted ROCE provide a reassuring backdrop.

Outlook for FY26/27 – momentum, integration, and brand refreshes

Management frames FY26/27 as a year of building momentum. The plan includes integrating Fentimans and Frobishers, delivering associated efficiencies from the second half, and pushing a strong brand activity pipeline. Notably, IRN-BRU and Rubicon will receive redesigns and further innovation launches are queued through the year.

Operationally, the company’s recent investment in manufacturing capacity and capability should continue to support service levels, innovation speed, and cost control. The next big date for investors is 31 March 2026, when full results will land.

The balanced view – positives and watchouts

• Positives – Revenue growth c.4%, margin up c.110 bps to c.14.7%, double-digit adjusted profit growth, and adjusted ROCE maintained at c.20% signal disciplined execution. The two acquisitions broaden the portfolio and position Barr for premium adult occasions.
• Watchouts – FUNKIN’s decline needs addressing, integration of two deals in quick succession adds complexity, and the Fentimans funding includes debt (not disclosed). The period also included 53 weeks, which is worth keeping in mind when comparing year-on-year revenue.

My take: this is a solid, well-signalled update. The strategy – tighten operations, invest in capacity, refresh core brands, and add targeted premium labels – makes sense. The proof point for FY26/27 will be delivery of integration synergies from H2 and visible traction from the innovation pipeline.

Quick reference – A.G. Barr FY25/26 at a glance

Item	Detail
Revenue	c.£437m (up c.4% vs £420m)
Adjusted operating margin	c.14.7% (vs 13.6%, up c.110 bps)
Adjusted profit before tax	Double-digit growth (exact figure not disclosed)
Adjusted ROCE	Maintained at c.20%
IRN-BRU	Modest H2 growth after flat H1
Rubicon and Boost	Good performances
FUNKIN	Declined
Frobishers acquisition	£13m, funded from net cash, completed towards period end
Fentimans acquisition	c.£38m, completed 2 February 2026, funded by cash and debt
Integration and synergies	FY26/27 integration; efficiencies expected from H2
Upcoming catalysts	Final results 31 March 2026; IRN-BRU and Rubicon redesigns; further innovation launches

Overall, A.G. Barr enters FY26/27 with a cleaner cost base, improving margins, and two fresh brands that target premium adult drinkers. Execution on integration and innovation will decide how much of that momentum converts into continued profit growth.